Australia's most trusted
source of pharma news
Friday, 22 August 2025
Posted 21 August 2025 AM
In an increasingly gruelling reimbursement market, Market Access is fast evolving into one of the most strategically important functions in pharma, according to experts.
US management consulting firm Russell Reynolds has named the position as a key player in pharma, insisting that it is "no longer a back-office function but a core strategic leadership position" that directly influences pricing, reimbursement, and ultimately, commercial success.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.